A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS

Neurol Neuroimmunol Neuroinflamm. 2019 Dec 5;7(1):e657. doi: 10.1212/NXI.0000000000000657. Print 2020 Jan.
No abstract available

Publication types

  • Published Erratum